Navigation Links
Morphotek®, Inc. Receives Beacon Award From CancerCare
Date:4/6/2011

rs and patient advocacy groups.  This information is shared regularly throughout the company to improve development strategies to identify new therapeutic agents and/or treatment regimens to facilitate patient care.  

About MorphotekMorphotek®, Inc., a subsidiary of Eisai Inc., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology.  The technology has been successfully applied to a broad variety of cell lines and organisms to yield genetically diverse offspring that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications.  The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease.  For more information, please visit www.morphotek.com.

About Eisai Inc.Eisai Inc. was established in 1995 and is ranked among the top-20 U.S. pharmaceutical companies (based on retail sales).  The company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business.  Eisai's areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care.  The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.  

Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania as well as manufacturing facilities in Maryland and North Carolina.  The company's ar
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Morphotek®, Inc. Announces an Agreement with Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues
2. Cellectis Receives Payment for License to Homologous Recombination Patents
3. China-Biotics Receives First U.S. Sales Order
4. BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens
5. Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer
6. ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardts Disease
7. Mylans Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg
8. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
9. EMD Serono Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application
10. Rensselaer professor Daniel Lewis receives NSF CAREER Award
11. Pacific Shore Holdings, Inc. Receives Symbol Change Approval From FINRA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  US-Australian drug discovery ... a Memorandum of Understanding with the Feinstein Institute ... New York to collaborate with the ... The collaboration brings together the drug ... clinical expertise of the Feinstein Institute in neurosciences ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 LC ... proteomics technologies, announced today that it is seeking ... an innovative multiplex PCR based targeted sequencing technology. ... sequence analysis, that enables accurate detection of rare ... and Omega-Primer™ technologies. The company will collaborate with ...
(Date:4/16/2015)... Spirax Sarco, the leader in ... newly designed, state-of-the-art website in the first quarter ... promotes the Spirax Sarco brand, company capabilities, and ... a site visitor might be looking for including ... serviced, the latest company news, careers, and much ...
(Date:4/16/2015)... 16, 2015 Cambridge Semantics ... driven by Semantic Web technology, and Informa ... and services for the academic and scientific, professional ... joint solution ‘Smart Data Lake for Clinical Trial ... the 2015 Bio-IT ‘Best of Show’ Award. ...
Breaking Biology Technology:Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Spirax Sarco website has a new look 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3
... Earnings Up 27%, GAAP Operating Earnings Up 32% ... Up 29%, GAAP Diluted EPS Up 32%, PALO ALTO, ... fiscal quarter 2008 revenues of,$282.5 million, representing an increase of ... fiscal year 2007, with strong orders and,excellent execution during the ...
... Share, SAN JOSE, Calif., Oct. 29 VNUS(R) ... of medical devices,for the minimally invasive treatment of venous ... ended September 30, 2008., Net revenues for the ... with $17.5 million for the third quarter of 2007. ...
... Results for the Nine Month Period Ended September ... ... A/S,(OMX: GEN) announced today results for the nine-month period ended,September 30, 2008. ... 667 million (USD 128 million) for the nine,month period ended September 30, ...
Cached Biology Technology:Varian, Inc. Reports Strong Fourth Quarter 2008 Results 2Varian, Inc. Reports Strong Fourth Quarter 2008 Results 3Varian, Inc. Reports Strong Fourth Quarter 2008 Results 4Varian, Inc. Reports Strong Fourth Quarter 2008 Results 5Varian, Inc. Reports Strong Fourth Quarter 2008 Results 6Varian, Inc. Reports Strong Fourth Quarter 2008 Results 7Varian, Inc. Reports Strong Fourth Quarter 2008 Results 8Varian, Inc. Reports Strong Fourth Quarter 2008 Results 9Varian, Inc. Reports Strong Fourth Quarter 2008 Results 10Varian, Inc. Reports Strong Fourth Quarter 2008 Results 11Varian, Inc. Reports Strong Fourth Quarter 2008 Results 12Varian, Inc. Reports Strong Fourth Quarter 2008 Results 13Varian, Inc. Reports Strong Fourth Quarter 2008 Results 14Varian, Inc. Reports Strong Fourth Quarter 2008 Results 15Varian, Inc. Reports Strong Fourth Quarter 2008 Results 16Varian, Inc. Reports Strong Fourth Quarter 2008 Results 17Varian, Inc. Reports Strong Fourth Quarter 2008 Results 18Varian, Inc. Reports Strong Fourth Quarter 2008 Results 19Varian, Inc. Reports Strong Fourth Quarter 2008 Results 20Varian, Inc. Reports Strong Fourth Quarter 2008 Results 21Varian, Inc. Reports Strong Fourth Quarter 2008 Results 22Varian, Inc. Reports Strong Fourth Quarter 2008 Results 23Varian, Inc. Reports Strong Fourth Quarter 2008 Results 24Varian, Inc. Reports Strong Fourth Quarter 2008 Results 25Varian, Inc. Reports Strong Fourth Quarter 2008 Results 26Varian, Inc. Reports Strong Fourth Quarter 2008 Results 27VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 3VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 4VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 5VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 6VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 7VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 8VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 9VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 10
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced ... Strategic Business Report" report to their offering. This ... US$ Thousands by the following Segments: Face Biometrics, and Voice Biometrics. ... Canada , Japan , Europe ... & Africa , and ...
(Date:3/23/2015)... 2015   HOYOS Labs , a leading global ... that the Company will demonstrate multiple biometrics-based technologies under ... at Connect:ID on March 23 through 25, 2015, in ... highlight the IEEE Biometric Open Protocol Standard; free biometrics-based ... access control system. BOPS was invented by HOYOS Labs ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... (ICB-2010) will be held in Los Angeles, November ... Hilton. It is the single most important meeting ... biotherapy (living organisms used to treat or diagnose ... faculty will educate clinicians and the public about ...
... Center for Molecular Medicine (MDC) Berlin-Buch and the ... and Charit in Berlin-Buch have gained new insights ... molecular repertoire. Dr. Max Werth, Katharina Walentin and ... (grainyhead-like 2, Grhl2), which regulates the composition of ...
... major new study that sounds a conservation alarm for the ... faring somewhat better, says a University of New Hampshire researcher ... Fred Short, UNH research professor of natural resources and director ... who contributed to "The Impact of Conservation on the Status ...
Cached Biology News:International Conference on Biotherapy to be held in the US 2New insights into the development of epithelial cells 2UNH's Fred Short adds seagrass data to major conservation study 2
Applications: Immunohistochemistry, ISH, FISH, CISH....
... TempliPhi 100 Amplification Kit, 100 reactions. ... sequencing in 4-6 h.Generate microgram quantities ... of starting material.Use amplified DNA directly ... from bacterial or M13 liquid cultures, ...
Immunogen: Synthetic peptide (KLH conjugated): L(506) S K S S S Q I R M S G L P A D N L A T(525) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Polypropylene test tube racks, used in Thermo Forma's line of Test Tube Rack holders...
Biology Products: